Literature DB >> 32776660

Association of dengue disease severity and blood group: A systematic review and meta-analysis.

Mohammad Rashidul Hashan1, Sherief Ghozy2, Amr Ehab El-Qushayri3, Rejwana Haque Pial4, Md Anwar Hossain4, Gulam Muhammed Al Kibria5.   

Abstract

Dengue disease encompasses various clinical manifestations including dengue fever (DF) and dengue hemorrhagic fever (DHF). In this article, we aimed to systematically review and analyze the association between different blood groups and severity of dengue. We searched nine databases for eligible papers reporting prevalence, distribution, and frequency of blood group type among dengue patients. Network meta-analysis using R software was used to analyze the data. Of a total of 63 reports screened, we included 10 studies with total sample size 1977 patients (1382 DF and 595 DHF). Blood group O was found to have the worst outcome with the highest risk of developing DF (P-score = 0.01) followed by group B (P-score = 0.34), group A (P-score = 0.64), and group AB (P-score = 1), respectively. Blood group O also had the worst outcome with highest risk of developing DHF (P-score = 0.1) followed by group B (P-score = 0.29), group A (P-score = 0.61), and group AB (P-score = 1), respectively. There was a significant increase (P-value <.001) in the overall odds risk of dengue infection among patients with Rhesus-positive blood groups [OR = 540.03; (95% CI = 151.48-1925.18)]. However, there was no significant difference in the odds risk of DF when compared to DHF according to Rhesus status (P-value = .954). This study identified the O blood group as a potential risk factor in predicting clinical severity in dengue patients which may be helpful in evaluating patients for their likely need for critical care.
© 2020 John Wiley & Sons, Ltd.

Entities:  

Keywords:  blood group; dengue; severity

Mesh:

Substances:

Year:  2020        PMID: 32776660     DOI: 10.1002/rmv.2147

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  5 in total

1.  IFITM3, FURIN, ACE1, and TNF-α Genetic Association With COVID-19 Outcomes: Systematic Review and Meta-Analysis.

Authors:  João Locke Ferreira de Araújo; Diego Menezes; Renato Santana de Aguiar; Renan Pedra de Souza
Journal:  Front Genet       Date:  2022-04-01       Impact factor: 4.599

Review 2.  The relationship between blood groups and risk of infection with SARS-CoV-2 or development of severe outcomes: A review.

Authors:  Pourya Shokri; Saeid Golmohammadi; Maryam Noori; Seyed Aria Nejadghaderi; Kristin Carson-Chahhoud; Saeid Safiri
Journal:  Rev Med Virol       Date:  2021-05-14       Impact factor: 11.043

3.  Transient Ischemic Attacks Preceding Ischemic Stroke and the Possible Preconditioning of the Human Brain: A Systematic Review and Meta-Analysis.

Authors:  Sherief Ghozy; Salah Eddine Oussama Kacimi; Mohamed Elfil; Mohamed Gomaa Sobeeh; Abdullah Reda; Kevin M Kallmes; Alejandro A Rabinstein; David R Holmes; Waleed Brinjikji; Ramanathan Kadirvel; David F Kallmes
Journal:  Front Neurol       Date:  2021-11-24       Impact factor: 4.003

4.  ABO Blood Groups Do Not Predict Schistosoma mansoni Infection Profiles in Highly Endemic Villages of Uganda.

Authors:  Rachel Francoeur; Alon Atuhaire; Moses Arinaitwe; Moses Adriko; Diana Ajambo; Andrina Nankasi; Simon A Babayan; Poppy H L Lamberton
Journal:  Microorganisms       Date:  2021-11-27

Review 5.  The impact of Parkinson's disease on manifestations and outcomes of Covid-19 patients: A systematic review and meta-analysis.

Authors:  Amr Ehab El-Qushayri; Sherief Ghozy; Abdullah Reda; Ahmed Mostafa Ahmed Kamel; Alzhraa Salah Abbas; Adam A Dmytriw
Journal:  Rev Med Virol       Date:  2021-07-14       Impact factor: 11.043

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.